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Role of CCR7 in Facilitating Direct Allosensitization
and Regulatory T-Cell Function in High-Risk
Corneal Transplantation
Yiping Jin,1,2 Sunil K. Chauhan,1,2 Daniel R. Saban,1 and Reza Dana1
PURPOSE. Chemokine receptor 7 (CCR7) is a key homing mol-
ecule for immune cell trafficking, including corneal antigen-
presenting cell (APC) migration from the inflamed cornea to
draining lymph nodes (LNs). Here, the authors investigated the
effect of CCR7-facilitated donor APC trafficking on allosensiti-
zation, regulatory T-cell (Treg) function, and graft survival in
corneal transplantation.
METHODS. CCR7/ or wild-type (WT) allogeneic corneal grafts
were transplanted onto the neovascularized high-risk recipient
beds. Two weeks later, the frequency of directly alloprimed
host T cells was measured by the IFN- ELISPOT assay. Treg
function was tested by a coculture suppression assay and an
IFN- ELISPOT assay. Kaplan-Meier analysis was performed to
evaluate graft survival.
RESULTS. The recipients of CCR7/ grafts had fewer migrated
donor APCs and lower frequency of IFN-–producing T cells in
the draining LNs. However, there was no statistically signifi-
cant difference in transplant survival between recipients of
CCR7/ and those of WT grafts. Tregs from the CCR7/
graft recipient group showed reduced regulatory potential for
the suppression of proliferation of naive T cells and direct
alloprimed T cells and expressed lower Foxp3 levels. In vitro
studies confirmed that mature CCR7major histocompatibility
complex class II CD86 graft-derived dendritic cells were
critical for Treg function.
CONCLUSIONS. Not only is CCR7-mediated donor-derived APC
trafficking to the draining LNs important in the initiation of
host T-cell priming, it is crucial for Treg-mediated tolerance.
(Invest Ophthalmol Vis Sci. 2010;51:816–821) DOI:10.1167/
iovs.09-3952
Alloantigens from grafted tissues are recognized by host Tcells through their direct or indirect presentation by anti-
gen-presenting cells (APCs) in the draining lymph nodes (LNs).
The direct pathway involves the recognition of intact donor
major histocompatibility complex (MHC) molecules on donor-
derived APCs, whereas the indirect pathway involves recogni-
tion of donor major or minor MHC-derived peptides processed
and presented by recipient APCs to host T cells.
Until recently, corneal grafts were considered entirely de-
void of resident APCs, giving rise to the tenet that alloantigen
recognition is mediated exclusively by the indirect pathway.
Recently, however, resident MHC class II APC populations
were identified in the cornea.1,2 These cells are capable of
expressing MHC class II antigen and accessory molecules
(CD40, CD80) after transplantation and of migrating to drain-
ing LNs of allograft recipients, where they can prime host T
cells through the direct pathway, especially in recipients of
high-risk grafts (i.e., transplantations performed in inflamed
host beds).3–5 This is important because although the survival
rate of grafts performed onto avascular and uninflamed low-risk
host beds approaches 90% under cover of topical steroids, well
more than 50% of corneal grafts performed onto high-risk graft
beds are rejected regardless of the immunosuppressive strategy
used.6 Given that corneal transplants constitute the most fre-
quent form of allograft performed and that allorejection re-
mains a significant clinical problem, development of a strategy
that could promote corneal graft survival without altering host
immune competence is a priority.
Chemokine receptor 7 (CCR7) is an essential homing mole-
cule that controls APC and T-cell migration to secondary lym-
phoid organs.7 We have previously demonstrated that CCR7 is
expressed by CD11bCD11cMHC class II APCs in the in-
flamed cornea and that it mediates trafficking of these cells to the
draining regional LNs.8 Thus, we hypothesized that CCR7 facili-
tates allorecognition in corneal transplantation and could be an
important target for promoting graft survival. Indeed, the effects
of targeting CCR7 on promoting graft survival have been demon-
strated in several transplantation models, with results varying
from limited to marked and even to permanent prolongation of
graft survival.9–11 However, these studies used plt mice as recip-
ients, CCL19-IgG administration to hosts, or CCR7/ grafted
tissue to CCR7/ recipients. Although these studies have pro-
vided significant insight into CCR7-mediated processes, they
could not be used to exclusively study the effect of CCR7 on
direct allosensitization because their approaches affect the hom-
ing of both APCs and T cells.
In the present study using a high-risk corneal transplanta-
tion model in which CCR7/ donor tissue was grafted onto
wild-type (WT) hosts, we demonstrated that CCR7 has para-
doxical effects on graft immunity. Although it mediates donor
APC migration to host LN and T-cell priming, it also promotes
the generation of Foxp3 Tregs, suggesting dual roles that can
promote or suppress graft longevity.
MATERIALS AND METHODS
Animals
Six- to 8-week-old male BALB/c and C57BL/6 (Taconic Farms, German-
town, NY) mice were used in all experiments. CCR7/ C57BL/6 mice
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were provided by Andrew Luster (Massachusetts General Hospital,
Boston, MA) and Martin Lipp (Maz-Delbrueck-center of Molecular Med-
icine, Berlin, Germany). They were housed in a specific pathogen-free
environment at the Schepens Eye Research Institute animal facility. All
procedures were approved by the Institutional Animal Care and Use
Committee, and all animals were treated according to the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision Research.
High-Risk Orthotopic Corneal Transplantation
The well-established procedures for corneal high-risk transplantation
have been described previously.3,12 Briefly, three interrupted 8-shaped
sutures (11–0 nylon, 50-m diameter needle; Sharpoint; Angiotech,
Vancouver, BC, Canada) were placed in the central corneas of BALB/c
mice to induce inflamed and neovascularized high-risk graft beds 14
days before orthotopic corneal transplantation. The central 2-mm di-
ameter corneal grafts were excised from CCR7/ or WT C57BL/6
mice with a trephine (Storz Instrument Co., St. Louis, MO) and mi-
croscissors. The recipient bed was prepared by excising 1.5-mm tissue
from the central corneas of BALB/c host mice. The prepared donor
corneal grafts were then transplanted onto the host bed with eight
interrupted 11–0 nylon sutures. The sutures were removed 7 days after
transplantation. All grafts were evaluated using slit-lamp biomicros-
copy weekly over 8 weeks. Grafts were defined as rejected when they
became opaque and the iris details could not be recognized clearly
using a standardized opacity-grading (range, 0–5) scheme.13
Flow Cytometry
Ipsilateral draining submandibular and cervical LNs were harvested at
48 hours after transplantation. Based on our previous studies, 48 hours
after HR transplantation is the peak time to identify donor-derived
APCs in host draining LNs.3 Single-cell suspensions of these LNs or
bone marrow–derived dendritic cells (BMDCs) were prepared. The
isolated cells were stained with the following antibodies: anti–CCR7
PerCP-Cy5.5, anti–CD86 fluorescein isothiocyanate (FITC; BD PharM-
ingen, San Jose, CA), anti–CD3 FITC, anti–Iab phycoerythrin (PE; BD
PharMingen), anti–CD4 FITC, anti–CD25 PE, and anti–forkhead box P3
(FoxP3) PECy5. Except where noted, primary and isotype-matched
antibodies were purchased from eBioscience (San Diego, CA). After
staining, the cells were analyzed on a flow cytometer (Beckman
Coulter).
Cell Sorting
T cells, CD4CD25 effector T cells (Teff), and CD4CD25 regula-
tory T cells (Treg) from the LNs of different graft recipients or naive
mice were isolated by magnetic separation using CD90 cells, CD4 T
cells, and Treg isolation kits (Miltenyi Biotec, Auburn, CA). More than
97% sorted CD90 cells were CD3, and more than 95% CD4CD25
Treg were Foxp3 in all the groups, as confirmed by flow cytometry.
Real-Time PCR
RNA was isolated (RNeasy Micro Kit; Qiagen, Valencia, CA) and reverse
transcribed (Superscript III Kit; Invitrogen, Carlsbad, CA). Real-time
PCR was performed using a PCR mix (TaqMan Universal PCR Master-
mix; Invitrogen) and preformulated primers for FoxP3 (assay ID
Mm00475156_ml) and GAPDH (assay ID Mm99999915_gl) (all Applied
Biosystems, Austin, TX). Results were analyzed by the comparative
threshold cycle method and normalized by GAPDH as an internal
control.
ELISPOT Assay
The ELISPOT assay was performed to delineate the contribution of
direct allosensitization to graft immunity, as described previously.14
Briefly, 96-well ELISPOT plates (Whatman Polyfiltronics, Rockland,
MA) were coated with 4 g/mL primary anti–IFN- mAb (BD PharMin-
gen) in sterile PBS overnight. The plates were then washed three times
with PBS and blocked for 1.5 hours with PBS containing 1% BSA. Next,
responder T cells were isolated from the draining LN ipsilateral to the
grafted eyes (n  8) and were added (5  105) to wells previously
loaded with irradiated donor splenocytes as APCs (5  105) in a final
volume of 200 L AIM-V medium. T cells harvested from LNs of
ungrafted animals served as controls. To test Treg suppression func-
tion, additional Treg (2.5  105) from each group were loaded. To
isolate the CD4-mediated response, 25 g/mL anti–CD8 (53–6.72)
mAb (BD PharMingen) were used.4,5 Cells were incubated for 48
hours. The plates were washed three times with PBS, then four times
with PBS containing 0.025% Tween 20. Biotinylated anti–IFN- detec-
tion mAbs were added at 2 g/mL (BD PharMingen) and were incu-
bated for 2 hours at room temperature. The washing steps were
repeated; after 1 hour of incubation with avidin-HRP, the plates were
washed again three times with PBS/0.025% Tween 20 and then three
times with PBS alone. The spots were developed by the addition of the
amino ethylcarbazole staining solution (Sigma-Aldrich, St. Louis, MO).
The resultant spots were counted and analyzed on a computer-assisted
ELISPOT image analyzer (Cellular Technology Ltd., Shaker Heights,
OH).
Generation of Bone Marrow-Derived
Dendritic Cells
BMDCs were generated as described by Lutz et al.15 Briefly, 6- to
8-week-old mice were humanely killed, and femurs were isolated. BM
cells (2 106) collected from femurs were seeded in Petri dishes in 10
mL culture medium (RPMI-1640 supplemented with 10% fetal calf
serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 g/mL streptomy-
cin, and 50 mM 2-ME) containing 200 U/mL granulocyte macrophage
colony-stimulating factor (GM-CSF; PeproTech, Rocky Hill, NJ). Me-
dium was changed every 2 days. On day 5 or 6, nonadherent and
loosely adherent cells were harvested as immature BMDCs. To gener-
ate mature BMDCs, 50 ng/mL TNF- (R&D Systems, Minneapolis, MN)
was added 24 hours before cell harvesting. The purity of the DCs,
determined by flow analysis of surface CD11c staining, was greater
than 97%. The maturity of the DCs was determined by flow analysis of
surface CD86 staining.
Suppression Assay
As described previously,16 T cells (1  105) were cocultured with
CD4CD25 Treg (5  104), T cell-depleted syngeneic splenocytes
(1  105), and 1 g/mL anti–CD3 antibody for 3 days. To measure the
allospecificity of Treg, CD4CD25 T cells (Teff, 1  105) and Treg
(5  104) were cocultured with allogeneic BMDCs without anti–CD3
stimulation. We tested three different ratios of BMDC/Treg (1:1, 1:5,
1:10); accordingly, the number of BMDCs was 5  104, 1  104, and
5  103 in different groups. The proliferation of stimulated T cells
without the addition of Treg was considered control proliferation with
0% suppression. Proliferation was measured using the BrdU incorpo-
ration assay (Millipore, Billerica, MA), and percentage suppression was
calculated using the following formula: % suppression  [(T-cell pro-
liferation without Treg  T cell proliferation with Treg)/T-cell prolif-
eration without Treg]  100.
Statistical Analysis
Data were presented as mean  SEM and analyzed by the two-tailed
Student’s t-test (Prism, version 4.0; GraphPad, San Diego, CA) between
groups. Values were considered statistically significant at P  0.05.
Kaplan-Meier analysis was adopted to construct survival curves, and
the log-rank test was used to compare the rates of corneal graft survival
in different settings.
RESULTS
The Impairment by Deletion of CCR7 Expression
on Donor-Derived APC
We analyzed the percentage of Iab (donor MHC class II) cells
among the CD3 cell population in the draining LNs of BALB/c
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recipients of corneal transplants (Iad) at 48 hours after cor-
neal transplantation (Fig. 1). Compared with the group receiv-
ing WT grafts, the group with CCR7/ grafts had a 43% lower
frequency of donor MHC class II cells (Fig. 1A). Flow cyto-
metric analysis of LN cells of recipients with WT grafts also
showed that most donor MHC class II (Iab) cells expressed
both CCR7 and CD86 (Fig. 1B), suggesting that CCR7 was
involved in the migration of mature MHC class IIhigh CD86
donor APCs.
Suppression of Direct Allosensitization
by Deletion of CCR7 Expression on
Donor-Derived APC
To determine the influence of CCR7/ donor tissue on direct
allosensitization, we investigated the frequency of IFN-–pro-
ducing cells 14 days after surgery (a time point just preceding
the manifestation of clinical rejection in the murine model). As
shown in Figure 2, a significant reduction in the directly
primed IFN- response was generated from the CCR7/ do-
nor group compared with the WT donor group. Anti–CD8
antibody was used to investigate the role of CCR7 in the direct
priming of CD4 versus CD8 host T cells. When limiting the
directly primed T cell response to the CD4 compartment, we
observed an even greater (20% vs. 13%) reduction in the direct
response, suggesting that the depletion of CCR7-mediated do-
nor APC trafficking led to an inhibition of recipient T cell
priming, especially among host CD4 T cells.
No Effect on Transplant Survival by Deletion of
CCR7 Expression on Donor-Derived APC
To test the effect of eliminating CCR7-facilitated direct al-
lorecognition in high-risk graft survival, CCR7/ C57BL/6
donor grafts were placed onto vascularized high-risk BALB/c
beds. Corneas from WT C57BL/6 grafted onto high-risk BALB/c
beds served as controls (Fig. 3). At the early time point (10–14
days), CCR7/ grafts had a modestly higher survival rate
(30%–40%) than WT grafts (20%). However, by 3 weeks, there
was no difference in graft survival between the two groups,
suggesting that the deletion of CCR7-facilitated direct al-
lorecognition may only lead to a slight delay in corneal graft
rejection.
FIGURE 1. Comparison of donor MHC class II cells in the recipient
draining LNs between recipient groups based on donor CCR7 expres-
sion. Draining LNs from the recipients were harvested 48 hours after
high-risk transplantation. (A) Total LN cells from hosts were isolated
and stained with anti–mouse CD3 FITC and anti–mouse Iab PE or
isotype control 48 hours after high-risk corneal transplantation. During
gating on the CD3 cell population, the percentages of donor-derived
Iab cells were compared between the WT and the CCR7/ donor
groups. Left: one representative of three independent experiments is
shown here. Right: values are expressed as the percentage of Iab cells
in a CD3 cell population of the host LNs. Results represent the mean
( SEM) of three samples per group (each sample consisted of LNs
from three mice; *P  0.01, t-test). (B) From the recipients with WT
donors, total LN cells were isolated and stained with anti–CD86 FITC,
anti–Iab PE, and anti–CCR7 PE-Cy5.5. During gating on Iab cell pop-
ulation, most donor APCs were CCR7CD86. Left: isotype control.
Results shown represent 1 of 3 independent experiments.
FIGURE 2. The direct pathway of allorecognition in corneal graft re-
cipients with CCR7/ or WT allografts. Responder T cells were
isolated from the draining LNs of graft recipients with WT or CCR7/
allografts (n  10) 14 days after transplantation and were stimulated
with C57BL/6 splenic APCs. The frequency of directly primed T cells
in grafted mice was measured by the IFN- ELISPOT assay. Anti–CD8
antibody was added to detect CD4 T-cell reactivity. Results are de-
picted as the number (mean  SEM) of spots per million responder T
cells loaded and represent 1 of 3 independent experiments (*P  0.05;
**P  0.01).
FIGURE 3. Fate of CCR7/ or WT corneal allografts placed in high-
risk vascularized host beds. BALB/c mice were grafted orthotopically
with high-risk corneal allografts from either CCR7/ (n  16) or WT
(n  16) C57BL/6 mice and were scored clinically for 8 weeks. Data
are reported as Kaplan-Meier survival curves.
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Effects on Suppressor Function of Host
Regulatory T Cells by Deletion of CCR7
Expression on Donor-Derived APC
To analyze the regulatory potential of Tregs generated in the
hosts of CCR7/ compared with WT donors, we first tested
the suppression of CD4CD25 Tregs on the proliferation of
CD3-stimulated naive T cells by using a coculture suppression
assay at 2 weeks after transplantation (Fig. 4). Tregs isolated
from the CCR7/ donor group showed significantly (46%)
lower efficacy in suppressing the proliferation of naive T cells
than those isolated from the WT donor group (26% vs. 49%;
P  0.01; Fig. 4A). We further studied the Treg suppressor
function on directly primed T cells from WT graft recipients at
high risk using the IFN--ELISPOT assay. Similar to the suppres-
sive effect on naive T-cell proliferation, the Tregs isolated from
the CCR7/ donor group showed a significantly (20%) lower
potential to suppress the IFN- secretion of directly primed T
cells compared with those isolated from the WT donor group
(P  0.03, Fig. 4B).
Foxp3 expression levels are critical in defining regulatory
activity16; therefore, we measured Foxp3 expression levels in
the Tregs from each group to explain the difference in Treg
function. Flow cytometric analysis of LN cell suspensions
showed that CD4CD25 cells from the CCR7/ donor
group had a lower Foxp3 expression level (mean fluorescence
[MFI], 46) than those from the WT donor group (MFI, 53). This
result was confirmed by our real-time PCR result, which
showed that CD4CD25 cells from the CCR7/ donor
group were expressing nearly half the levels of Foxp3 mRNA
compared with cells from the WT donor group (Fig. 4C).
Promotion of Suppressor Function of Host Tregs
by Donor Tissue–Derived Mature APC
Because we demonstrated that CCR7 is important for the
migration of mature donor APCs though we observed no en-
hancement of survival among CCR7/ grafts, we hypothe-
sized that not only are mature APCs relevant for allosensitiza-
tion, they may play a critical role in promoting Treg function in
high-risk corneal transplantation. To test this hypothesis, we
compared the potential of mature BMDCs (MHC class
IIhighCD86) and immature BMDCs (MHC class IIlowCD86) to
promote Treg function in an allogeneic setting using an in vitro
coculture assay (Fig. 5). C57BL/6 mature- or immature BMDCs
and naive BALB/c CD4CD25 T cells (Teff) were cocultured
with CD4CD25 Tregs at indicated DC/Treg cell ratios. Tregs
cocultured with mature BMDCs showed a higher suppressive
effect on Teff than did those cocultured with immature BMDCs
(Fig. 5A). In addition, Tregs cocultured with mature BMDCs at
different cell ratios showed a direct relationship between their
suppressor function and the numbers of mature BMDCs
present in the culture (Fig. 5B). These results clearly demon-
strate that mature BMDCs promote Treg suppressor function,
supporting our hypothesis that CCR7-mediated trafficking of
FIGURE 5. Mature dendritic cells facilitate Treg suppressor function.
(A) Mature or immature BMDCs were cocultured with allogeneic
CD4CD25 Teff and CD4CD25 Treg from naive mice. Total cell
number of DC/Treg/Teff is 1:5:10. Treg suppression potency was
compared between mature and immature BMDC groups. (B) Treg
suppressor potential was also tested at different mature BMDC/Treg
cell number ratios. Total cell number of Treg/Teff is 1:2. The x-axis
shows the different ratios of mature BMDC/Treg. Results are depicted
as the percentage of suppression (mean  SEM) and represent the
results of 1 of 3 independent experiments (*P  0.05).
FIGURE 4. Comparison of recipients’ Treg function based on donor
tissue CCR7 expression. Tregs (CD4CD25) were sorted from the
draining LNs of recipients at 2 weeks after transplantation to evaluate
their functionality. (A) Treg suppression assay showing the level of
CD3-mediated proliferation of naive BALB/c CD4 T cells with the
Tregs from different recipient groups using BrdU assay (left). Accord-
ingly, the suppression effect of these Treg was calculated as % sup-
pression  [(T-cell proliferation without Treg  T-cell proliferation
with Treg)/T-cell proliferation without Treg] 100 (right). Results are
depicted as the percentage of suppression (mean  SEM) and repre-
sent the results of 1 of 3 independent experiments (*P  0.01). (B)
IFN- ELISPOT assay showing frequencies of directly primed T cells in
different graft recipients. Responder T cells from the recipients at high
risk with WT allografts were cocultured with the Tregs isolated from
the recipients of CCR7/ or WT allografts and were stimulated with
C57BL/6 APCs. The results are depicted as the number (mean  SEM)
of spots per million responder T cells loaded and represent the results
1 of 3 independent experiments (*P  0.05). (C) CD4CD25 Tregs
isolated from the draining LNs of different graft recipient groups. Left:
flow cytometric histogram showing expression levels (mean fluores-
cence intensity) of Foxp3 in these Tregs. Right: values are expressed as
the fold change of Foxp3 mRNA expression levels of these Tregs in the
CCR7/ donor group over the WT donor group, normalized to
GAPDH expression. Results represent the mean ( SEM) of four
samples per group (each sample consisted of 1 LN), and the data are
representative of two independent experiments (*P  0.01).
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graft-derived mature APCs to draining LNs are essential for Treg
function.
DISCUSSION
Allorecognition is the result of host T cells detecting non–self-
antigens by either the direct or the indirect pathway. Here, we
report the relevance of CCR7-dependent donor-APC trafficking
to the host lymph nodes on T-cell allosensitization and Treg
function.
In this study, we first demonstrated a significant reduction
in the frequency of donor MHC class II cells in the draining
LN of CCR7/ graft recipients, suggesting that CCR7 deletion
impairs donor-derived APC migration to the host draining LNs.
This impairment led to a blunted expansion of directly al-
loprimed IFN-–secreting Th1 cells in the draining LNs of
recipients with CCR7/ grafts compared with those in the
WT donor control group. IFN-–secreting cells have been as-
sociated with effecting corneal transplant destruction at 2
weeks, and they correlate with the acquisition of donor-spe-
cific, delayed-type hypersensitivity.4 The Th1-type response
represents the dominant effector T-cell population for acute
rejection of corneal transplants.13,17,18 Indeed, the deletion of
directly primed CD4 Th1 cells by the use of MHC class II
knockout donor grafts has shown the promotion of graft sur-
vival in high-risk corneal transplantation.3 These data led us to
hypothesize that CCR7 deletion in the graft would lead to
prolonged corneal transplant survival.
Interestingly, though we noted a slight delay in the rejec-
tion rate of CCR7 / grafts, the overall rate of rejection was
nearly identical (80%) to that of WT grafts. We had observed
only a 40% to 50% reduction in graft-derived APC trafficking
from CCR7 / grafts compared with from WT grafts (Fig. 1);
nevertheless, the fact that the overall graft rejection rate was
no different from that observed with WT donor tissue led us to
hypothesize that CCR7 function is potentially also relevant for
the induction of tolerance.
Recent studies have shown that oral tolerance cannot be
induced in CCR7-deficient mice that display impaired migra-
tion of DCs from the intestine to the mesenteric lymph nodes,
and small intestinal lamina propria-DCs induce T cells to pro-
duce IL-4 and IL-10 by presenting intestinal epithelial cell-
associated antigen in a CCR7-dependent manner.19,20
CD4CD25 Tregs, which constitute 5% to 10% of CD4 T
cells, have been shown to play a central role in inducing and
maintaining tolerance in a number of clinical settings and
animal models of transplantation.21–24 Our data demonstrate
that Tregs isolated from the draining LNs of recipients receiv-
ing CCR7/ grafts have a lower potential for suppressing the
proliferation of naive T cells and alloprimed T cells. In addition,
these Tregs express lower levels of Foxp3, an important ob-
servation; far more relevant than Treg frequency is their level
of Foxp3 expression, which directly correlates with their po-
tential for suppressing effector T cells.15 These observations
suggest that CCR7-mediated pathways are relevant not only in
the allopriming of CD4 T cells but in establishing the regula-
tory effect of Tregs on these effector T cells.
CCR7 governs the migration of both semi-mature (MHC
class II CD86low) and mature (MHC class II CD86high) DCs
to the lymphoid tissues. These DC populations have also been
shown to be crucially involved in the induction of peripheral
tolerance.25 Under noninflammatory steady state conditions,
semi-mature DCs induce alloantigen-specific T-cell anergy and
derive de novo differentiation of naturally occurring Tregs
from CD4 T cells.26 Here, our results showed that most WT
donor-derived APCs in the host draining LNs are mature and
are of the MHC class II CD86highCCR7 phenotype. In addi-
tion, our data from in vitro coculture experiments that mimic
the interaction among DC, Tregs, and T cells in the lymphoid
compartment after transplantation confirm that MHC class
IIhigh CD86high DC are more efficient than their MHC class
IIlowCD86 counterparts in promoting Treg function, as dem-
onstrated previously.27–29 Together, these findings clearly ex-
plain why the deletion of CCR7 from donor-derived APCs leads
to impaired Treg function in corneal graft recipients.
In conclusion, CCR7-mediated donor APC migration to the
draining LNs after corneal transplantation promotes both al-
losensitization and Treg function in graft recipients. As such,
CCR7 has a “paradoxical” and pleiotropic role in alloimmunity;
though it clearly promotes direct priming by facilitating graft-
derived APC migration to LNs, it also amplifies Treg function,
underscoring the complexities of targeting APC trafficking for
the promotion of transplant survival.
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